NCT02451579

A Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy

A Randomized, Double-blind, Placebo-controlled, Prospective Clinical Trial Evaluating the Role of Systemic Antihistamine Therapy in the Reduction of Adverse Effects Associated With Topical 5-aminolevulinic Acid Photodynamic Therapy

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (estimated)
• Sponsor: Goldman, Butterwick, Fitzpatrick and Groff · Academic / Other
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

A double-blind, placebo controlled study conducted at a single study site. Evaluating the role of systemic antihistamine therapy in the reduction of adverse effects associated with topical 5-aminolevulinic acid photodynamic therapy.

Conditions

• Actinic Keratoses

Interventions

Type	Name	Description
DRUG	Antihistamine Cetirizine Hydrochloride	Prophylactic use of antihistamine prior to and following topical 5-aminolevulonic acid photodynamic therapy
OTHER	Placebo	Use of placebo prior to and following topical 5-aminolevulonic acid photodynamic therapy

Timeline

• Start date: 2015-02-01
• Primary completion: 2016-12-01
• Completion: 2017-01-01
• First posted: 2015-05-22
• Last updated: 2017-03-01

Locations

1 site across 1 country: United States